"Evaluation Of ALBA® Device for Upper Extremity Motor Function In Adults With Subacute And Chronic Acquired Brain Injury"
Stroke
About this trial
This is an interventional treatment trial for Stroke focused on measuring Stroke, Acquired Brain Injury, Adults
Eligibility Criteria
Inclusion Criteria: Patients of Los Coihues clinic Diagnosis of acquired brain injury. Cognitive capacity and language that allows understanding and following the therapist's instructions. Trunk control. Subacute and chronic stage (up to 2 years post injury). Upper extremity paresis able to perform movements with eliminated gravity (modified MRC 2). Exclusion Criteria: Cardiovascular instability Visual or acoustic limitations. Severe hypertonia (≥3 Ashworth Scale). Upper extremity with passive joint limitation and/or traumatic injury. Neuropsychological alteration (global aphasia, severe attentional deficit, spatial perception alteration). Moderate to severe cognitive-behavioral alterations that do not allow the understanding of instructions. Severe alterations of consciousness. Deficit in cephalic control. Severe deficit in sedentary balance.
Sites / Locations
- Clínica Los CoihuesRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ALBA
Conventional Therapy
25 minutes of therapy with ALBA and 20 minutes with conventional therapy per session for 5 days a week during 4 weeks.
45 minutes conventional therapy per session for 5 days a week during 4 weeks.